Study guide
2.7 Risk Assessment Instruments Beyond Braden: Norton, Braden Q, Braden QD, Wagner, and University of Texas
NAWCCB WCC Wound Care Certified Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
About the NAWCCB WCC Exam How to Use This Study Guide
2 Assessment: Skin & Tissue Foundations
1.1 Skin Anatomy, Physiology, and Barrier Function 1.2 Phases of Wound Healing & Cellular Events 1.3 Acute vs. Chronic Wounds & Etiology Classification 1.4 TIME and MEASURE Assessment Frameworks 1.5 Wound Bed Tissue Types & Periwound Assessment 1.6 Pain Assessment: Scales, Wound Pain Types, and Procedural Analgesia 1.7 Psychosocial History, Cognitive Status, and Functional Assessment 1.8 Skin Integrity Across the Lifespan: Neonatal, Pediatric, Adult, and Geriatric
3 Assessment: Diagnostic Tools & Risk Assessment
2.1 Vascular Assessment: ABI, TcPO2, and Arterial/Venous Doppler 2.2 Neuropathy & Monofilament Testing in Diabetic Patients 2.3 Pressure Injury Risk Assessment: Braden Scale Subscales & Scoring 2.4 NPIAP Pressure Injury Staging (Stages 1-4, Unstageable, DTPI) 2.5 Exudate Characterization, Biofilm (NERDS/STONEES), & Wound Culture 2.6 Laboratory Interpretation in Wound Care: Albumin, Prealbumin, ESR, A1C, CBC, and CMP 2.7 Risk Assessment Instruments Beyond Braden: Norton, Braden Q, Braden QD, Wagner, and University of Texas
4 Treatment: Dressing Selection & Debridement Modalities
3.1 Principles of Dressing Selection by Exudate & Moisture Balance 3.2 High-Absorbency Dressings: Alginates, Hydrofibers, and Foams 3.3 Barrier & Hydrating Dressings: Hydrocolloids, Transparent Films, and Hydrogels 3.4 Antimicrobial & Biofilm Dressings: Silver, Cadexomer Iodine, and Honey 3.5 Debridement Modalities: Sharp, Enzymatic, Autolytic, Mechanical, & Biosurgical
5 Treatment: Advanced Therapies & Specialized Management
4.1 Negative Pressure Wound Therapy (NPWT) Indications, Settings, & Precautions 4.2 Compression Therapy Protocols & ABI Safety Cutoffs 4.3 DFU Off-loading Hierarchy: TCC, RCW, and Therapeutic Footwear 4.4 Support Surfaces, Microclimate Control, & Repositioning Protocols 4.5 Advanced Biologics, Cellular/Tissue Products (CTPs), & HBOT
6 Reevaluation & Wound Healing Trajectory
5.1 Healing Trajectory Benchmarks & Percent Area Reduction (PAR) 5.2 Serial Wound Measurement, Depth Profiling, & Digital Photography 5.3 Treatment Plan Reassessment & Non-Healing Wound Escalation Triggers 5.4 Biofilm Progression & Systemic Infection Re-evaluation 5.5 Palliative Wound Management: Odor, Exudate, and Pain Control 5.6 Validated Healing Instruments: The PUSH Tool, BWAT, and Evaluating Adherence
7 Risk Reduction & Prevention Strategies
6.1 Pressure Injury Prevention: Bundles, Turning Schedules, & Heel Floating 6.2 Moisture-Associated Skin Damage (MASD) & Incontinence-Associated Dermatitis (IAD) 6.3 Infection Control, Contact Precautions, & Environmental Hygiene 6.4 Prevention of Skin Tears & Medical Adhesive-Related Skin Injuries (MARSI) 6.5 Diabetic & Venous Ulcer Recurrence Prevention Protocols 6.6 At-Risk Populations: Spinal Cord Injury, Stroke, Critical Care, and Cognitive Impairment
8 Patient & Caregiver Education
7.1 Patient & Caregiver Wound Care Teaching & Self-Management 7.2 Diabetic Foot Self-Inspection & Footwear Education 7.3 Nutritional Assessment & Dietary Interventions for Wound Healing 7.4 Off-loading Compliance & Patient Mobility Education 7.5 Recognizing Complications, Infection Signs, & When to Seek Care 7.6 Educating the Interprofessional Team & Developing Educational Media
9 Administration & Program Management
8.1 Wound Care Documentation Standards & Clinical Records 8.2 Admission Wound Screening & Present on Admission (POA) Documentation 8.3 Interdisciplinary Team Roles & Clinical Care Coordination 8.4 Quality Improvement Metrics & HAPI Tracking Programs 8.5 Wound Care Formulary Management & Resource Utilization
10 Legal, Ethical, & Scope of Practice
9.1 Informed Consent, Treatment Refusal, & Autonomy in Wound Care 9.2 HIPAA Compliance & Clinical Photography Privacy Standards 9.3 Scope of Practice Across WCC-Eligible Professions (RN, LPN, PT, OT, DPM, MD/DO, PA) 9.4 HAPI Malpractice Liability & Documentation Defense 9.5 Ethical Considerations in Non-Healing Wounds & End-of-Life Skin Care 9.6 Regulatory Compliance, Coding Standards, & Audit Protection
2.7 Risk Assessment Instruments Beyond Braden: Norton, Braden Q, Braden QD, Wagner, and University of Texas
Key Takeaways Explain This Topic AI
Blueprint objective 1.07 names six instruments — Braden, Braden Q, Braden QD, Norton, Wagner, and the University of Texas Diabetic Foot Scale — so knowing only the Braden Scale leaves most of this objective uncovered.
The Norton Scale scores five subscales from 1 to 4 for a total of 5 to 20, with lower scores indicating higher risk; a score of 14 or below is the commonly used at-risk threshold.
The Braden Q adds tissue perfusion and oxygenation to the adult Braden subscales for a pediatric total of 7 to 28, with 16 or below indicating risk.
The Braden QD extends risk scoring to medical device-related injury with a total range of 0 to 20, where a score of 13 or above identifies the at-risk patient — the scoring direction is inverted relative to every other Braden tool.
The University of Texas system outperforms Wagner for predicting amputation because it grades depth on one axis and grades infection and ischemia separately on the other, which Wagner conflates.
Last updated: August 2026
Risk Assessment Instruments Beyond Braden
Section 2.3 covered the Braden Scale in depth. Objective 1.07 , however, names six instruments: Braden, Braden Q, Braden QD, Norton, Wagner, and the University of Texas Diabetic Foot Scale . Exam items in this objective typically supply a patient of a specific age or diagnosis and ask which tool applies , or supply a score and ask what it means. The traps are the scoring direction and the population each tool was validated in.
1. The Norton Scale — the original adult pressure risk tool
Developed by Doreen Norton in 1962 , this is the oldest pressure injury risk instrument still in use, and it remains common in the United Kingdom and in some long-term care settings.
Five subscales , each scored 1 (worst) to 4 (best) :
- Physical condition — good, fair, poor, very bad
- Mental condition — alert, apathetic, confused, stuporous
- Activity — ambulant, walks with help, chairbound, bedbound
- Mobility — full, slightly limited, very limited, immobile
- Incontinence — none, occasional, usually urinary, urinary and fecal
Total range: 5 to 20. As with Braden, lower means higher risk. The widely used threshold is 14 or below indicates risk , with below 12 indicating high risk ; some institutions set the onset of risk at 16.
Norton versus Braden: Norton is faster and simpler, but it omits nutrition and does not separate friction and shear from mobility — two of the strongest predictors — which is why Braden displaced it as the dominant instrument in the United States. Norton is more sensitive but less specific, generating more false positives.
2. The Braden Q — pediatric pressure risk
The Braden Q adapts the adult Braden Scale for children, validated for patients from roughly 21 days to 8 years .
Seven subscales , each scored 1 to 4 :
- The three intensity and duration of pressure subscales: mobility, activity, sensory perception
- The three tissue tolerance subscales: moisture, friction and shear, nutrition
- Plus the pediatric addition: tissue perfusion and oxygenation
That seventh subscale is the point of the tool. Critically ill children are frequently hemodynamically unstable, hypoxemic, or on vasopressors, and perfusion status is a stronger driver of pediatric pressure injury than it is in ambulatory adults.
Total range: 7 to 28. Lower means higher risk. A score of 16 or below indicates at-risk.
3. The Braden QD — pediatric plus medical device risk
The Braden QD was developed to address the fact that the majority of pediatric and neonatal pressure injuries are device-related , which no earlier tool scored. It was validated across a wide pediatric range, from premature neonates through age 21 , in both ICU and non-ICU settings.
It comprises seven subscales : five immobility-related items (drawn from the Braden Q concepts of mobility, sensory perception, friction and shear, nutrition, and tissue perfusion and oxygenation) plus two device-related items :
- The number of medical devices in contact with the skin
- The repositionability of those devices and the skin protection applied beneath them
Total range: 0 to 20.
The direction trap: on the Braden QD, a higher score means higher risk , and the at-risk threshold is 13 or above . This is the inverse of the Braden Scale and the Braden Q, where lower is worse. Exam items exploit this reversal, so anchor it: Braden and Braden Q go down toward danger; Braden QD counts devices upward.
4. The Wagner (Wagner-Meggitt) Diabetic Foot Classification
A single-axis depth and necrosis grading system, and still the most widely cited diabetic foot scale:
Grade Description
0 Intact skin — no open lesion; may have a deformity, callus, or a healed prior ulcer (a pre-ulcerative or at-risk foot)
- 1 Superficial ulcer, not extending into deeper tissue
- 2 Deep ulcer penetrating to tendon, capsule, or bone, without abscess or osteomyelitis
- 3 Deep ulcer with abscess, osteomyelitis, or joint sepsis
- 4 Localized gangrene — forefoot or heel
- 5 Gangrene of the entire foot , requiring major amputation
Wagner appears throughout wound care because coverage criteria reference it — hyperbaric oxygen therapy is a covered benefit for Wagner Grade 3 or higher diabetic foot ulcers that have failed standard therapy.
Its weakness: Wagner conflates depth, infection, and ischemia onto one axis. A clean, well-perfused deep ulcer and an ischemic infected deep ulcer can both be graded 2 or 3, yet they carry entirely different amputation risks.
5. The University of Texas Diabetic Wound Classification
The University of Texas (UT) system resolves Wagner's weakness with a two-axis grid . Depth runs across the grades; infection and ischemia run down the stages.
Grade (depth):
- 0 — pre-ulcerative or post-ulcerative site, fully epithelialized
- 1 — superficial wound not involving tendon, capsule, or bone
- 2 — wound penetrating to tendon or capsule
- 3 — wound penetrating to bone or joint
Stage (complication):
- A — clean wound: no infection, no ischemia
- B — infection present
- C — ischemia present
- D — infection and ischemia both present
A wound is reported as a grade-and-stage pair: "UT 2B" is a wound to tendon or capsule with infection; "UT 3D" is a wound to bone with both infection and ischemia.
Why the exam prefers UT: risk of amputation rises predictably as you move right across grades and down through stages , and validation studies show UT predicts outcome more accurately than Wagner precisely because infection and ischemia are graded independently. A UT 1A heals reliably; a UT 3D carries a very high amputation risk.
6. Matching the tool to the patient
The single most common exam error in this objective is applying an adult pressure tool to a child, or a pressure tool to a diabetic foot. Anchor the mapping:
- Adult pressure injury risk → Braden (or Norton where institutional policy specifies it)
- Pediatric pressure injury risk → Braden Q
- Neonatal or device-heavy pediatric risk → Braden QD
Diabetic foot ulcer severity → Wagner (depth and gangrene) or, preferably, University of Texas (depth plus infection and ischemia)
Objective 7.02 then closes the loop: the score is not the deliverable. Using the risk assessment findings to select preventative measures is. A Braden of 12 driven by a moisture subscale of 1 calls for an incontinence protocol and barrier products; the same total driven by a mobility subscale of 1 calls for an active support surface and a turning schedule.
- Instrument Population Subscales / Axes Score Range Risk Direction At-Risk Threshold
- Braden Adults 6 (five 1–4, friction/shear 1–3) 6 – 23 Lower = higher risk ≤ 18 at risk; ≤ 9 very high
- Norton Adults 5, each 1–4 5 – 20 Lower = higher risk ≤ 14 at risk; < 12 high risk
Braden Q Children ~21 days – 8 years 7, each 1–4 (adds tissue perfusion/oxygenation) 7 – 28 Lower = higher risk ≤ 16 at risk
Braden QD Neonates (premature) through age 21 7 subscales: 5 immobility items + 2 medical device items 0 – 20 Higher = higher risk ≥ 13 at risk
Wagner Diabetic foot ulcer Single axis: depth and gangrene Grade 0 – 5 Higher = more severe Grade 3+ qualifies for HBOT consideration
University of Texas Diabetic foot ulcer Two axes: Grade 0–3 depth × Stage A–D 0A – 3D Right and down = worse 3D carries the highest amputation risk